Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

8.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 52.50
  • 52 Week Low: 7.60
  • Currency: UK Pounds
  • Shares Issued: 165.93m
  • Volume: 181,322
  • Market Cap: £13.27m
  • RiskGrade: 348
  • Beta: 0.02

Renalytix surges on takeover approach

By Michele Maatouk

Date: Monday 04 Mar 2024

LONDON (ShareCast) - (Sharecast News) - Renalytix surged on Monday after saying it had received an unsolicited takeover approach from "a large and well-capitalised publicly listed strategic diagnostics company".
The artificial intelligence-enabled in vitro diagnostics company said the firm was currently in the process of evaluating an acquisition.

As a result, Renalytix has begun a review of all available options and has started a formal sale process.

"The formal sale process will enable the board and its advisers to conduct an orderly process and engage more widely with all potentially interested parties, with a view to optimising the outcome for Renalytix's shareholders," it said.

The company also said that as part of a review of funding options currently being explored, its directors are considering possible sources of funding, including equity and debt.

"The company is in advanced discussions with certain existing shareholders as well as potential new equity and debt providers," it said.

As at 3 March, Renalytix has cash on hand of $2.3m and marketable securities of about $1.4m.

At 1135 GMT, the shares were up 63% at 65.2p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 8.00p
Change Today -0.25p
% Change -3.03 %
52 Week High 52.50
52 Week Low 7.60
Volume 181,322
Shares Issued 165.93m
Market Cap £13.27m
Beta 0.02
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.58% above the market average17.58% above the market average17.58% above the market average17.58% above the market average17.58% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
93.67% below the market average93.67% below the market average93.67% below the market average93.67% below the market average93.67% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average
Income Not Available
Growth
34.09% below the market average34.09% below the market average34.09% below the market average34.09% below the market average34.09% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

RENX Dividends

No dividends found

Trades for 07-Oct-2024

Time Volume / Share Price
16:41 33,696 @ 8.00p
16:35 50,000 @ 8.00p
15:32 58 @ 8.50p
14:25 189 @ 7.72p
14:11 275 @ 7.72p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page